SynthesisJournal for immunotherapy of cancer2021

Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis.

Alice Tzeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.